Abstract: Uracil in DNA is a deleterious event that may arise either by cytosine deamination or misincorporation of dUTP. Consequently, cells from all free-living organisms have developed strategies to protect their genome against the presence of uracils, by using uracil DNA glycosylase (UNG) and deoxyuridine triphosphatase (dUTPase) enzymatic activities. In the viral kingdom, some (namely poxviruses and herpesviruses) but not all of the DNA viruses encode their own UNG and dUTPase to control uracilation of their genome. Some retroviruses, which are RNA viruses using DNA as an intermediate of replication, also encode dUTPase. Surprisingly, though most of nonprimate lentiviruses encode dUTPase, primate lentiviruses such as HIV-1, HIV-2 or SIV do not. Because these latter viruses also replicate in nondividing cells where the dUTP/dTTP ratio is high, it is probable that they have found other ways to fight against the emergence of uracilated-viral transcripts. Indeed, recent studies showed that HIV-1 efficiently controls both the cytosine deamination and the dUTP misincorporation. The viral Vif protein acts in preventing the packaging into viral particles of the host-derived cytosine deaminase APOBEC3G enzyme, while the viral integrase domain of the Gag-Pol precursor mediates the packaging of the host-derived uracil DNA glycosylase UNG2 enzyme. In the absence of Vif or UNG2, HIV-1 viral transcripts are heavily charged in uracil bases leading to inactivation of the virus.
The integrity of cellular DNA is constantly jeopardized by a large number of exogenous or endogenous agents as well as by some cellular processes [49] . The incorporation and retention of uracil bases in DNA strands represent a permanent danger as it triggers mutations, but cell developed several mechanisms to highly control uracilation of its genome. Viruses that replicate their genome in a cellular environment favoring the incorporation of uracils in DNA also evolved strategies to counteract the uracilation of viral DNA transcripts. In this review, we describe what are the consequences of uracils in DNA for the replication of some viruses, and what are the molecular mechanisms used by HIV-1 to avoid uracilation of viral transcripts.
URACILS IN DNA: ORIGIN AND CONSEQUENCES
Uracil is a natural base present in RNA that is replaced by thymine in DNA. However, uracils may be abnormally found in DNA via two distinct mechanisms including either spontaneous or enzymatically-induced cytosine deamination to uracils and dUTP misincorporation in place of dTTP.
Deamination of cytosine residue in DNA is a genotoxic event in cell due to the creation of G: U mismatched pairs that leads, if unrepaired before the next round of replication, to G: A mismatch generating G-to-A transition mutations. Spontaneous deamination of cytosines is a frequent event that has been estimated between 60 to 500 times per day and *Address correspondence to this author at the Unité des Virus Emergents. per genome [49] . The modified form of cytosine, namely the 5-methylcytosine, is subjected to spontaneous deamination 3 to 4 times more rapidly than its unmodified form [30] . Some chemical agents, like nitric oxide (NO) [105] ) or bisulfites [13] may enhance the frequency of cytosine deamination. Two kinds of cellular enzymes are able to convert cytosine to uracil, the (cytosine-5)-methyltransferase and the cytidine deaminase. In mammalian cells, 2 to 7% of cytosines are methylated and located in areas involved in gene expression, the CpG islets. Cytosines within CpG islets are essentially converted to 5-methylcytosines by the (cytosine-5)-methyltransferase enzyme. The first step of the conversion starts by the formation of a covalent bond between enzyme and cytosine that leads to transient dihydropyrimidinic intermediate products that are highly subjected to spontaneous deamination. Then, the enzyme catalyzes the transfer on the cytosine base of a methyl group provided by the methyl donor S-adenosylmethionine. Thus, a cytosine residue can be converted to uracil residue upon the abortive action of (cytosine-5)-methyltransferase [84] or in cellular conditions where the concentration of Sadenosylmethionine is low [86] .
The cytidine deaminase APOBEC family includes members that share similar catalytic activity. Among these members, are found APOBEC1 (apolipoprotein B mRNA editing catalytic subunit 1), AID (activation-induced cytidine deaminase), APOBEC2, also referred as APOBEC1-related cytidine deaminase 1 (ARCD-1) and proteins APOBEC3A to APOBEC3G. At this time, no function has been attributed to APOBEC3A, APOBEC3D and APOBEC3E. APOBEC1 is responsible for the tissue-specific deamination of the cytosine residue C6666 of the apolipoprotein B mRNA leading to a premature stop codon and the expression Fig (1) . Depiction of the biosynthesis pathway of nucleotides in mammalian cells. De novo synthesis of AMP, GMP and UMP leads to the generation of dATP, dGTP, dCTP, dTTP and dUTP nucleotides that are substrates for cellular polymerases and therefore are incorporated into DNA.
of a truncated form of apolipoprotein B [68, 93] . APOBEC 1 acts exclusively in deaminating apolipoprotein B mRNA in cells, although when expressed in bacteria, it is also able to deaminate cytosines present in DNA [3, 34] . The expression of AID is restricted to activated B lymphocytes [64] and is required to generate antibody diversity in allowing the class-switch recombination and the somatic hypermutation processes [63, 79] . AID is specific of singlestranded DNA and acts in deaminating cytosine present in the immunoglobulin gene locus [9, 19] . Concerning APOBEC3 proteins, the seminal publication from Sheehy and collaborators [85] identifying the APOBEC3G enzyme as a host cell restriction factor that impedes HIV-1 replication, led to a spectacular interest as revealed by the high number of reports published during the last three years (see below).
Incorporation of dUTP into DNA leads to A: U mismatched pairs that are not mutagenic. Indeed, uracil that replaces thymine will be paired with adenine to generate A: T matched pairs in the next round of replication. In eukaryotic cells, dUTP is synthesized either from the conversion by a dCTP deaminase of dCMP to dUMP or from the phosphorylation of dUDP arising from UDP under the action of rNDP reductase (Fig. (1) ). dUMP is an essential intermediate for the synthesis of intracellular dTTP pool. Thus, dUMP is always present in cell and represents a permanent source of dUTP. DNA polymerases, including reverse transcriptases, but excluding vent and pfu DNA polymerases from hyperthermophilic archea [33] , are not able to discriminate dUTP from dTTP rendering the incorporation of dUTP as the major source of uracils in DNA. In physiological conditions, there is a low concentration of dUTP in cell (∼ 0.2 µM) in comparison to that of dTTP (37±30 µM) [95] . The intracellular ratio dUTP/dTTP has been determined between 0.3 and 3%. However, in some cell types such as HT29 cell line, primary spleen cells, macrophages or quiescent lymphocytes, dUTP levels are high and even exceed those of dTTP [2, 17, 38] .
One main consequence of uracils in DNA is the enhancement of recombination frequency in eukaryotic cells that leads to DNA fragmentation [22, 32] . Moreover, accumulation of uracils in promoter sequences may alter gene expression due to the failure of some transcription factors to recognize their target sequence [27, 101] .
CELLULAR STRATEGIES TO COUNTERACT URACILS IN DNA
To impede deleterious effects of uracils in DNA, cells have evolved in setting up two mechanisms to prevent incorporation and retention of uracils in DNA. The first mechanism [22, 36, 100] involves dUTPase that acts directly on the intracellular dUTP pool level by hydrolyzing dUTP to dUMP and inorganic pyrophosphate. The role of dUTPase is to maintain a low level of intracellular dUTP but also to contribute to the biosynthesis of nucleotides derived from thymidine. In prokaryotes, the total deficiency in dUTPase is lethal, and in conditions where the deficiency is only partial, it is associated with an increased time of replication and an increased frequency of spontaneous mutations and recombinations [22, 36, 100] . In S. cerevisiae cells, the total deficiency in dUTPase is lethal except if dTMP is exogenously added, indicating that lethality was probably the consequence of a blockage in DNA synthesis due to the absence of dTTP [32] . The human dUTPase gene is composed of four exons that encode two isoforms generated by alternative splicing, one expressed in nucleus and the other one expressed constitutively in mitochondria [44] . The expression of nuclear form is dependent on cell cycle with a high expression level in S phase that becomes undetectable in G0 and G1 phases.
The second mechanism involves uracil DNA glycosylases (UNG) that recognize and excise uracil residues that are already present in DNA using two distinct base excision repair (BER) pathways, i. e. the short and the long patch repair pathway (Fig. (3) ). UNG excises the uracil base leading to an abasic site that is further cleaved on its 5' side by an apurinic/apyrimidinic (AP)-endonuclease, leaving a free 3'-OH end. In the short patch repair pathway, the removal of the baseless nucleotide and the insertion of correct nucleotide are performed by the polymerase ß via its lyase and polymerase activities, respectively. The sealing of the remaining nick is performed by the XRCC1-DNA ligase 3 complex. In the long patch repair pathway, polymerases such a pol ε and/or pol δ associated with proliferating cell nuclear antigen (PCNA) and replication factor C (RFC) allow the polymerization of a 2-10 nucleotides flap from the AP-endonuclease-induced free 3'-OH end through stranddisplacement polymerization, which is then cut by flap endonuclease 1 (FEN1). A patch of the same size is then synthesized by DNA polymerase and PCNA and ligated by DNA ligase I. Other mechanisms of DNA repair that included nucleotide excision repair and homologous-or nonhomologous recombination also exist in cells [37] . Sequence comparisons between UNGs expressed from mammals, bacteria, yeast, or herpesvirus show a high degree of homology. In human cells, several enzymes with uracil DNA glycosylase activity have been reported, namely TDG, MBD4, SMUG, UNG1 and UNG2 [43] . The human ung gene encodes two UNG isoforms generated by alternative splicing, the UNG2 form (314 aminoacids) displaying a nuclear localization signal and the UNG1 form (305 aminoacids) displaying a mitochondrial localization signal [67] . These forms differ in their N-terminal sequence. Sequences downstream the position 44 of UNG2 and sequences downstream the position 35 of UNG1 are identical. The UNG1 mitochondrial form is constitutively expressed in cells, while the expression of the UNG2 nuclear form depends on cell cycle with high levels in S phase and low levels in G0 phase [26] .
VIRAL STRATEGIES TO COUNTERACT URACILS IN DNA
Viruses belonging to the herpesviridae, poxviridae and retroviridae family have evolved in encoding their own dUTPase and/or UNG, arguing that these viruses seem to be sensitive to the presence of uracils in their genome.
Members of the Herpesviridae family replicate their genome in the nucleus of infected cells. They possess a linear double-stranded DNA genome that rapidly circularizes in nucleus. These viruses infect distinct cell types and some have the ability to infect nondividing cells, like neurons. Alpha-herpes viruses, like Herpes simplex (HSV) or Varicella zooster (VZV), and gamma-herpes viruses, like Epstein-Barr virus (EBV), encode enzymes of deoxynucleotides metabolism, including dUTPase [69] and thymidine kinase, and DNA repair enzymes such as UNGs. Studies have demonstrated that HSV-1 or VZV deficient for dUTPase replicated well in cultured dividing cells [11, 28] where dUTP is low and cellular dUTPase is high. dUTPaseminus HSV-1 was severely impaired in replication, neuroinvasiveness and reactivation from latency in mice nervous system where the levels of dUTP are high and those of cellular dUTPase and UNG are low [77] . In addition, dUTPase or thymidine kinase deficient HSV-1 displayed enhanced frequency of mutations [75] . Mutations of the UNG gene of HSV-1 or VZV did not impaired replication in dividing cells in culture [78] but led to alterations of viral propagation in a in vivo murine system [76] . The situation is somewhat different for beta-herpes viruses, such as cytomegalovirus (CMV), which do not encode a functional dUTPase nor any other dNTP biosynthesis enzymes and might only rely on enzymes expressed in cellular targets [10] . However, CMV encodes a viral UNG and this virallyencoded enzyme was somewhat dispensable for viral replication in highly dividing cells, although DNA replication was slightly delayed and the replicative cycle was longer. CMV-encoded UNG was much more required for viral propagation in slowly or nondividing cells, as UNGdeficient CMV exhibited markedly delayed DNA synthesis in these cells [16, 70] . Further studies have suggested that UNG is a crucial determinant in the transition from early-to late-phase CMV DNA replication that plays a role in excising uracils incorporated during early phase replication to create sites that serve as substrates for initiation of recombination-dependent replication late in infection [16] . These data support the notion that CMV UNG is required to compensate for low levels of cellular UNG in nondividing cells.
Members of the Poxviridae family replicate their linear double-stranded DNA genome exclusively in the cytoplasm of infected cells. Although deletion of the dUTPase gene of the vaccinia virus prototypic member had no effect on viral propagation in actively dividing cells [29] , deletion of the UNG gene altered viral replication in the same cell type [24, 62] . Vaccinia virus-encoded UNG had also an essential function in the viral DNA synthesis that was independent of its glycosylase activity [18] . It is probable that the lack of replication of UNG-deficient vaccinia virus could be attributed to the fact that cellular UNG enzymes which are mainly localized in nucleus could not gained access into the cytoplasmic viral capsid, where viral replication occurs, suggesting that these viruses have to encode their own UNG to target it to the site of the viral DNA synthesis.
Members of the Retroviridae family replicate their RNA genome via a double-stranded DNA intermediate generated by the virally-encoded reverse transcriptase, which is then integrated in the genome of host cell. Retroviruses have captured a dUTPase gene on at least three different occasions, highly suggesting that dUTP hydrolysis must have conferred a strong selective advantage for these viruses. Retroviral dUTPase is a part of the polymerase precursor protein, expressed either downstream of the integrase domain for human or murine endogenous retroviruses ERV-L [4, 15] or between the reverse transcriptase and the integrase domains for some lentiviruses [23, 58, 59] . Retroviral dUTPase is expressed as a fusion protein with the nucleocapsid domain for ß-retroviruses, such as MazonPfizer monkey virus (MPMV) or murine mammary tumor virus (MMTV) [5] . As a general rule, the dUTPase protein is predicted to be encapsidated into budding particles and to be in close spatial proximity of the reverse transcription process [23] . The exact role of dUTPase in the replication of ß-retroviruses has not yet been established. In contrast, studies on the role of dUTPase of nonprimate lentiviruses, like visna-maedi virus (MMV), caprine arthritis-encephalitis virus (CAEV), feline immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV), revealed that virallyencoded dUTPase is dispensable for viral replication in dividing cells, but is required for fully efficient replication in nondividing cells, such as primary macrophages that are their natural target cells [47, 88, 94, 99, 102] . The proviral DNA of dUTPase-negative EIAV or CAEV was shown to be uracilated suggesting that in the absence of viral dUTPase, the reverse transcriptase was highly efficient at dUTP incorporation in place of TTP [88, 99] . It must be noted that this uracilation is not mutagenic per se. Experimental infection of goats or cats with dUTPase-deficient CAEV or FIV showed reduced viral load associated with only a slight increase of mutation rates [46, 97] . G-to-A transitions were observed in dUTPase-deficient proviruses, but they were very different, both in terms of frequency and of sequencecontext, from the bona fide G-to-A hypermutations observed in Vif-negative HIV-1 DNA. This small excess of G-to-A subsitutions had been hypothesized to result from dUTP incorporation in place of dCTP and opposite to guanine in the first strand DNA. If this happens, this must be a very rare event, as revealed by in vitro assays with recombinant RT, owing to the actual ratio of dCTP and dUTP in a cell [57, 74] .
Uracilation of DNA by dUTP incorporation, although generally not mutagenic, may nevertheless lead to a strong impairment of replication. High levels of uracils in both DNA strands could lead to excessive strands breaks promoted by the cellular DNA repair pathway. In macrophages infected by dUTPase deficient EIAV there was a reduction of integrated provirus and a strong (up to 300 fold) reduction in transcription [88] probably because of faulty recognition of transcriptional signals.
Collectively, these reports highlight the fact that high levels of dUTP are present in lentivirus target cells, that this could lead to uracilation of proviral DNA and reduced viral replication and explain why a captured dUTPase gene may have been selected for.
PRIMATE HIV-1 LENTIVIRUS STRATEGY TO COUNTERACT CYTOSINE DEAMINATION IN VIRAL DNA
Primate lentiviruses, such as human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV), are phylogenetically closely related to nonprimate lentiviruses and replicate their genome in nondividing cells where dUTPase and UNG expression levels are low. The intracellular dUTP pool level in macrophages and lymphocytes has been estimated to be 30% of that of dTTP [2, 17, 38] , highly enhancing the probability to misincorporate dUTP during the HIV-1 life cycle. Because these viruses do not encode dUTPase or UNG, they need to acquire enzymatic activities to counteract the uracilation of their genome. Recent studies have unveiled strategies used by HIV-1 to fight uracils arising in viral DNA either by dUTP misincorporation during the reverse transcription process or by the recently described cytosine deamination of reverse transcripts.
HIV-1 viral particles have the property to incorporate the host-derived cytidine deaminases APOBEC3G [85] and APOBEC3F [103, 112] . APOBEC3G incorporation occurs via either a specific association with the RNA-recruiting nucleocapsid (NC) domain of Gag [1, 12, 51, 110] , or a nonspecific association with viral or cellular RNA [40, 92] . The virion-associated APOBEC3G triggers G-to-A hypermutations due to the deamination of cytosines in the minus-strand viral cDNA in a CC context [35, 45, 53, 111] , while APOBEC3F deaminates cytosines in a TC context. Providing that these uracils were not recognized and eliminated by virion-associated UNG (see below), these mutations will be fixed in the plus-strand DNA following second strand cDNA synthesis. Together, these two cytidine deaminase specificities account for the majority of observed G-to-A hypermutations.
The retention of uracils in neosynthesized viral DNA is incompatible with virus survival as shown by the degradation of uracilated viral transcripts prior to integration [53, 55] . To protect its genome from the cytosine deamination process, HIV-1 encodes the Vif protein that has the unique property to bind and to induce polyubiquitination of APOBEC3G followed by its proteosomal degradation, leading to a substantial reduction of the packaging of APOBEC3G. The Vif-mediated degradation of APOBEC3G required an interaction between Vif and a Skp-1-cullin-F box (SCF)-like complex including the cellular Cul5, elongins B and C, and Rbx1 [56, 60, 109] . Moreover, HIV-1 Vif was polyubiquitinated and degraded in the presence of APOBEC3G through a Vif-APOBEC3G complex [61] . In addition, it has been reported that Vif can trigger the depletion of cellular APOBEC3G through a pathway that involved the inhibition of the translation of APOBEC3G mRNA [39, 89] . The protective role of HIV-1 Vif was efficient to restrict the packaging of APOBEC3G expressed in human cells but not that of APOBEC3G expressed in African green monkey (AGM) or rhesus monkey cells or that of APOBEC3 expressed in murine cells [31, 55] . This species-specific restriction was attributed to the presence in the APOBEC3G protein of a charged amino acid at position 128 that is a critical determinant for its interaction with Vif [7, 52, 82, 106] . APOBEC3B also played a role in deaminating cytosines of HIV-1 genome, while APOBEC1, APOBEC3A and APOBEC3C did not [6, 48, 103, 113] . APOBEC3B and APOBEC3C were reported to be potent inhibitors of SIV [107] . Remarkably, a recent study revealed that the function of human APOBEC3G as a restriction factor for HIV-1 in human resting T lymphocytes or in monocytes could be alleviated by subsequent mitogen stimulation of T cells or by induction of differentiation of monocytes into macrophages [14] . In mitogen-stimulated cells and differentiated-induced monocytes, APOBEC3G was recruited in an enzymatically incompetent, highmolecular-mass ribonucleoprotein complex creating a favorable environment for productive HIV-1 infection. In unstimulated cells and monocytes, APOBEC3G was part of an enzymatically competent, low-molecular-mass ribonucleoprotein complex acting in blocking HIV-1 infection, explaining why these cells were refractory to HIV. This antiviral activity did not trigger massive G-to-A hypermutations, indicating that APOBEC3G-mediated DNA editing was not involved, but rather involved a nonenzymatic mechanism that is Vif insensitive. Consistently, studies have reported that some deaminase-defective APOBEC3G variants still exhibited anti-HIV activity [66, 87] . Altogether, these findings indicate that the antiviral function of APOBEC3G may be the result of two separable properties, one involving uracilation of the DNA and an other one that is not associated to G-to-A hypermutation. The precise mechanism of the deamination-independent antiviral activity of APOBEC3G remains elusive, however.
Infectivity of simple retroviruses like murine leukemia virus (MLV) was strongly inhibited by the expression of human APOBEC3G and APOBEC3B, but was unaffected by the expression of murine APOBEC3 [6, 20, 42] . This difference correlated with the ability of MLV to package human APOBEC3G and APOBEC3B, but not murine APOBEC3, into MLV virion particles, explaining the resistance of MLV to its cognate APOBEC3 [20] . Human Tcell leukemia virus-1 (HTLV-1) oncoretroviruses infectivity was profoundly affected by the packaging of human APOBEC3G, although no significant accumulation of G-to-A mutations was reported [65, 81] , suggesting that APOBEC3G exerted its antiviral activity through a deaminase-independent mechanism. Feline foamy virus (FFV), a member of the foamy retrovirus subfamily spumaretrovirinae, was susceptible to feline APOBEC3-mediated viral DNA editing that was counteracted by the expression of the FFV-encoded Bet protein [50] . Hepatitis B viruses (HBV), the replication of which requires a reverse transcription step, was susceptible to APOBEC3G and APOBEC3F-mediated antiviral activity. Depending on the cellular type infected by HBV, it has been observed either no G-to-A mutations [80, 98] or G-to-A mutations on both plus-and minus-DNA strand [90] .
Beside its role as antiviral factor, APOBEC3G plays a physiological role in markedly inhibiting retrotransposition of endogenous retroviruses, namely mammalian longterminal-repeat (LTR) retroposons such as murine IAP and MusD copies [25] . These retroelements share with infectious retroviruses a reverse transcription process during which APOBEC3G functions to edit retroviral DNA preventing further movement. In contrast, a non-LTR retrotransposon, such as human LINE-1 (long interspersed nucleotide element-1), evaded human APOBEC3G inhibition by replicating in the nucleus, thus avoiding its genome to be targeted by APOBEC3G that is a cytoplasmic protein [96] . Although the physiological relevance was unclear, it has been reported that overexpression of human APOBEC3C can inhibit yeast retrotransposon Ty1 [21] .
In conclusion, some proteins of the APOBEC family exert an antiviral effect against various viruses which replicate through a reverse transcription step, HBV included. Part of this antiviral effect can be due to cytosine deamination of the nascent reverse transcripts, leading to uracilated cDNAs which are subsequently degraded by, still uncharacterized, enzymatic activities in target cell. To counteract this cellular defense mechanism, HIV have evolved by using the Vif protein which acts by preventing the packaging of the negative factor into the viral capsid where reverse transcription takes place. It must be noted that Vif has no direct effects on uracils per se.
HIV-1 LENTIVIRUS STRATEGY TO COUNTERACT dUTP MISINCORPORATION IN VIRAL DNA
Beside the emergence of uracils in viral DNA by cytosine deamination that was counteracted by HIV-1 Vif, there exists the possibility to uracilate viral DNA v i a dUTP misincorporation. As noted before, the intracellular dUTP pool level in macrophages and lymphocytes is quite high [2, 17, 38] , and so is the probability to misincorporate dUTP in place of TTP during reverse transcription. It must be stated again that this kind of uracilation is not supposed to be mutagenic, but could nevertheless lead to the degradation of cDNA and abortion of the viral life cycle. Therefore, it is probable that HIV-1 is endowed with specific enzymatic activities to counteract dUTP misincorporation.
In a yeast double-hybrid assay, HIV-1 Vpr protein was found to bind a human clone encoding a UNG polypeptide deleted from 52 aminoacid residues corresponding to UNG2 or UNG1 [8] . Because HIV-1 Vpr is packaged into HIV-1 virions particles, the question arises to check whether UNG was packaged into virions via a specific association with Vpr. Using sucrose gradient purified virions, we have identified that the UNG2 isoform was a virion-associated protein that was recovered in both HIV-1 wild-type and Vprdeficient particles, indicating that Vpr was not required to package UNG2 [104] . Further studies using GST pull-down assays demonstrated that UNG2 had the ability to associate with the integrase (IN) domain of the HIV-1 Gag-Pol precursor, in addition to its association with HIV-1 Vpr. Fig. (2) . Prevention of uracil incorporation in newly synthesized reverse transcripts in HIV-1 infected cells. UNG2 is packaged into virions via a specific interaction with the integrase (IN) domain of the Gag-Pol precursor and acts to repair dUTP misincorporated during reverse transcription. The uracil-free proviral DNA is then imported into the nucleus and expressed. Virus produced from UNG2-deficient cells is devoid of UNG2. Reverse transcription allows uracil incorporation from dUTP into the first strand cDNA. Unrepaired uracil lead to abnormal second strand synthesis. The damaged and uracilated proviral DNA recruits UNG2 and other repair activities from the nucleus and is degraded. This interaction was confirmed by demonstrating that viral particles proficient for Vpr but deficient for IN or containing point mutations in IN that inhibited the IN-UNG2 interaction were unable to package endogenous UNG2, clearly indicating that IN is the sole determinant that allowed the packaging of UNG2 [71, 104] . Note that one other group found that overexpressed HIV-1 Vpr directed the packaging of overexpressed UNG2 into pseudoparticles [54] , while one another group found that overexpressed Vpr directed the degradation of UNG2 and prevented its packaging [83] . The opposite conclusions in those studies could result from either aberrant behavior of overexpressed and tagged Vpr and UNG2 or by the lack of gradient purification of bona fide virions.
HIV-1 virus produced from cells depleted of UNG2 by RNA interference-mediated knock-down were unable to propagate either in dividing or nondividing cells, indicating that the presence of UNG2 within viral particle is indispensable to obtain infectious virus [74] . Viral infectivity could be rescued by transfection in UNG2-deficient producer cells of a UNG2 gene engineered to escape siRNA silencing. Interestingly, viral infectivity was also restored by overexpression in UNG2-deficient producer cells of a siRNA-insensitive UNG2 protein containing point mutations that abrogate its binding to HIV-1 Vpr, thus confirming that the association of UNG2 with HIV-1 Vpr has no influence on HIV-1 propagation. The blockage of UNG2 catalytic activity by overexpression in producer cells of the UNG inhibitor Ugi led to the production of noninfectious virus, revealing the importance of the uracil removal capability of UNG2 in the viral life cycle.
The impaired propagation of UNG2-depleted virions was due to the failure of accumulation of viral transcripts. This impairment was reminiscent of that observed for ∆Vif viruses that were unable to counteract cellular APOBEC3G and thus generated uracilated transcripts that are degraded in the cytoplasm of infected cells [53, 55] . The viral infectivity of UNG2-deficient virus could be rescued by targeting overexpressed dUTPase into UNG2-deficient viral particles, demonstrating that the failure of UNG2-deficient virus to replicate was due to uracils in viral DNA arising from misincorporated dUTP. Despite the presence of uracils in transcripts from UNG2-deficient virus, no G-to-A mutations were found nor were there any excess mutations with the Vpr-deficient virus. These findings were not unexpected as HIV-1 RT readily incorporated dUTP opposite to dAMP, but strongly resisted at incorporating dUTP opposite to dGMP.
Although not mutagenic, the presence of uracils as dU-rA pairs in transcripts led to the degradation of the proviral DNA in target cell, thus blocking HIV-1 replication. The mechanism(s) by which this degradation occured is not yet characterized. For UNG2-deficient viruses, one could envisage that uracils will be efficiently incorporated in the viral minus strand cDNA. Uracils in minus strand are known to alter the RNase H activity and could disrupt the second strand synthesis [41] , leaving breaks and/or RNA primers. Once in the nucleus of target cell, the heavily uracilated and damaged proviral DNA would induce catastrophic DNA repair on both strands leading to degradation of the provirus (Fig. 2) .
The main difference in the role of UNG2, either protective from uracilation when associated to the reverse transcription/preintegration complexes or destructive of uracilated proviruses in the nucleus of target cells would therefore result from difference in both timing and environment. During reverse transcription in the capsid and or in the cytoplasm of target cell, the UNG2 would exert a protective role because the UNG2-containing HIV-1 replication complex contains all the activities needed to fully repair an uracil in the minus strand cDNA. We will see below what we already know about the mechanisms of uracil repair by this replication complex.
It is noteworthy that both UNG2 and APOBEC3G exert their effects very early in the viral life cycle, as soon as the minus strong stop cDNA begins. Accorddingly, both Vif and UNG2 defects must be transcomplemented in producing cells and not in target cells.
URACIL REPAIR MECHANISM BY HIV-1 VIRION
HIV-1 viral lysate contained all enzymatic activities to convert G: U mispair to G: C pair [72] . Although the cellular BER process required the intervention of an APendonuclease, we [72] and other [54] failed to detect the presence within HIV-1 particles of human AP-endonucleases APE1 or APE2 suggesting that the HIV-1 specific uracil repair process may use a virally-encoded unknown enzymatic activity that may play a role similar to that of an APendonuclease enzyme. To understand how HIV-1 repaired dUTP misincorporated in viral transcripts, we have developed a cell-free system and we demonstrated that the concerted action of UNG2 and HIV-1 reverse transcriptase (RT) can replace rG: dU mispairs to rG: dC pairs. This uracil repair was successfully accomplished because UNG2 was active on RNA/DNA heteroduplexes, and because HIV-1 RT displayed an unexpected dNTP-dependent APendonuclease activity [74] on either DNA-DNA homoduplex or RNA/DNA heteroduplex. The HIV-1 specific BER mechanism was similar to that of the cellular long-patch excision repair mechanism, in that it used a DNA strand displacement step. However, these mechanisms diverged in that cellular BER utilized a combination of multiple enzymatic activities including AP-endonuclease, DNA polymerase, PCNA, RFC, FEN1 and DNA ligase 1 to replace a stretch of 2-10 nucleotides containing the baseless nucleotide, while HIV-1 BER utilized only HIV-1 RT to cleave 5' to the baseless nucleotide leading a free 3'-OH end that was used to polymerize longer stretch of nucleotides (Fig. (3) ). It is worth noting that HIV-1 repair does not require FEN1 nor ligase because the strand displacement activity of the reverse transcriptase will reconstitute the strand ahead of the lesion. We have found that the repair was most efficient when uracil was not more than 25 to 30 nt from the 3'end of the cDNA. This may be because the reverse transcriptase needs a 3'OH-end to attach to the cDNA and this could reflect the size of the RT-UNG2 complexes onto the cDNA.
The composition of this replication complex is presently unknnown. Individuallly, UNG2 interacts with Vpr, integrase and RT. RT interacts also with integrase and with NC. Is there a large holo-enzyme? Could it be that these interactions result in unmasking new enzymatic activities in either the reverse transcriptase and/or integrase?
VIRALLY-ASSOCIATED UNG2 WILL NOT REPAIR DEAMINATED CYTOSINE.
Typically, the mechanism of uracil repair requires a strand template allowing polymerase to incorporate the correct nucleotide in place of the baseless nucleotide. It has been demonstrated that the single-stranded minus DNA was the substrate for APOBEC3G and that the removal of viral RNA template by the RNase H activity of RT was a prerequisite for the cytosine deamination process [91, 108] . This means that the UNG2-RT complex might be unable to repair uracils arising from cytosine deamination because of the absence of RNA template to guide repair. Indeed, the recovery of G-to-A mutations in Vif-deficient viral transcripts confirmed that uracils arising from cytosine deamination were fixed in minus-strand DNA and therefore escaped the viral UNG2-mediated uracil repair pathway.
CONCLUDING REMARKS
Viruses have evolved in acquiring genes that allow them to replicate in an adverse cellular environment, like those promoting the synthesis of uracil-substituted viral transcripts that impairs replication. Viruses that replicate in nondividing cells, such as neurons or macrophages, are equipped with their own UNG and/or dUTPase enzymes to compensate the low levels of cellular UNG and dUTPase enzymes. Viruses that replicate in the cytoplasm of cells also encode their own UNG and/or dUTPase to compensate the fact that UNG and dUTPase enzymes are essentially localized in nucleus. Since HIV-1 infects nondividing cells and since reverse transcription takes place mainly in the cytoplasm, the ability to package host UNG2 and to encode Vif are crucial events for virus survival. HIV-2 and SIV replicate, like HIV-1, in the cytoplasm of nondividing cells, but no UNG2 was recovered in viral particles [73] . To cope with the danger of dUTP misincorporation, HIV-2 may have evolved in packaging another member of the human UNG family or in packaging the human dUTPase enzyme, and SIV may have evolved in packaging the simian UNG2 counterpart. Whether other retroviruses such as MLV or HTLV-1, or HBV, were sensitive to dUTP misincorporation and how they resist to uracilation of their proviral DNA remains to be established.
We have showed that forcing the retention of uracils in viral transcripts represented an innate immune response against viruses. Note that dUTP levels in infected versus noninfected cells have not been evaluated, raising the possibility that dUTP levels may be increased in cells in response to a viral infection, thus representing a second barrier against viral invasion. Therefore, any strategies aiming to enhance uracil levels in transcripts of a variety of viruses may reinforce the innate response contributing to the potent inhibition of viral replication. It is expected that such a strategy will not be easily hurdled by viral mutations, in contrast to the frequency of multi-drug resistant HIV-1 mutants found in patients under highly active antiretroviral therapy (HAART). We can thus envisage new therapeutic roads targeting dUTP misincorporation to control HIV-1 infection by manipulating interactions between host cell factors and viruses. These may include drugs that act in impeding the interaction between HIV-1 integrase and UNG2 to block the packaging of UNG2 during virus budding, or drugs that impede the interaction between HIV-1 reverse transcriptase and UNG2 to inhibit the viral uracil repair mechanism. However, to rule out any effect on host genomic DNA, these drugs will have to target exclusively the viral partner involved in the interaction. Also, it would be important to target the AP-endonuclease activity of HIV-1 reverse transcriptase, when the molecular mechanism(s) will be understood.
